Nichiban Reports Major Shareholding by Daiichi Pharmaceuticals

TOKYO, May 14 (Pulse News Wire) – Nichiban CO.,LTD. (4218.T) disclosed that as of March 31, 2026, Daiichi Pharmaceutical Industry Co., Ltd.

Holds 33.52% of its voting rights. Daiichi Pharmaceutical Industry Co., Ltd. owns 33.52% of Nippon's shares but does not impose restrictions on the company’s operations or require approval for certain activities.

Nippon operates independently while maintaining a cooperative relationship within the Daiichi Pharmaceutical Group, leveraging synergies through shared resources such as technology. In the fiscal year ending March 31, 2026, transactions between Nippon and Daiichi Pharmaceutical Industry Co., Ltd. amounted to ¥30 million.